Invention Grant
US07919088B2 Treatment and delay of onset of synucleinopathic and amyloidogenic disease
有权
突触核蛋白病和淀粉样变性疾病的治疗和延迟发作
- Patent Title: Treatment and delay of onset of synucleinopathic and amyloidogenic disease
- Patent Title (中): 突触核蛋白病和淀粉样变性疾病的治疗和延迟发作
-
Application No.: US11842054Application Date: 2007-08-20
-
Publication No.: US07919088B2Publication Date: 2011-04-05
- Inventor: Dale B. Schenk , Kate Dora Games , Manuel J. Buttini , Tamie J. Chilcote , Edward Rockenstein , Eliezar Masliah
- Applicant: Dale B. Schenk , Kate Dora Games , Manuel J. Buttini , Tamie J. Chilcote , Edward Rockenstein , Eliezar Masliah
- Applicant Address: US CA South San Francisco US CA Oakland
- Assignee: Elan Pharmaceuticals, Inc.,The Regents of the University of California
- Current Assignee: Elan Pharmaceuticals, Inc.,The Regents of the University of California
- Current Assignee Address: US CA South San Francisco US CA Oakland
- Agency: Alston & Bird LLP
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
The invention provides improved agents and methods for treatment of diseases associated with synucleinopathic diseases, including Lewy bodies of alpha-synuclein in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the Lewy body. The methods are particularly useful for prophylactic and therapeutic treatment of Parkinson's disease.
Public/Granted literature
- US20080175838A1 Prevention And Treatment of Synucleinopathic And Amyloidogenic Disease Public/Granted day:2008-07-24
Information query
